144 related articles for article (PubMed ID: 8749031)
1. Pretreatment with beta-endorphin facilitates the attenuation of delta-opioid receptor-mediated antinociception caused by delta-opioid receptor antisense oligodeoxynucleotide.
Tseng LF; Narita M; Kampine JP
Eur J Pharmacol; 1995 Dec; 287(2):169-72. PubMed ID: 8749031
[TBL] [Abstract][Full Text] [Related]
2. Antisense oligodeoxynucleotide to a delta-opioid receptor messenger RNA selectively blocks the antinociception induced by intracerebroventricularly administered delta-, but not mu-, epsilon- or kappa-opioid receptor agonists in the mouse.
Wang HQ; Kampine JP; Tseng LF
Neuroscience; 1996 Nov; 75(2):445-52. PubMed ID: 8931008
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of spinal delta-opioid receptors in mice selectively enhances the attenuation of delta-opioid receptor-mediated antinociception by antisense oligodeoxynucleotide.
Narita M; Tseng LF
Eur J Pharmacol; 1995 Sep; 284(1-2):185-9. PubMed ID: 8549623
[TBL] [Abstract][Full Text] [Related]
4. The effect of pretreatment with a delta 2-opioid receptor antisense oligodeoxynucleotide on the recovery from acute antinociceptive tolerance to delta 2-opioid receptor agonist in the mouse spinal cord.
Narita M; Mizoguchi H; Kampine JP; Tseng LF
Br J Pharmacol; 1997 Feb; 120(4):587-92. PubMed ID: 9051295
[TBL] [Abstract][Full Text] [Related]
5. Antisense oligodeoxynucleotide to a delta-opioid receptor given intrathecally blocks i.c.v. administered beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
Life Sci; 1994; 55(7):PL127-31. PubMed ID: 8041224
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of [D-Ala2, Glu4]deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxynucleotide to an opioid delta receptor.
Bilsky EJ; Bernstein RN; Pasternak GW; Hruby VJ; Patel D; Porreca F; Lai J
Life Sci; 1994; 55(2):PL37-43. PubMed ID: 8015351
[TBL] [Abstract][Full Text] [Related]
8. Use of antisense oligodeoxynucleotide to delta-opioid receptor mRNA in the study of turnover of delta-opioid receptors in the spinal cord of the mouse.
Narita M; Mizoguchi H; Nagase H; Tseng LF
Psychopharmacology (Berl); 1997 Oct; 133(4):347-50. PubMed ID: 9372533
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligodeoxynucleotide to a delta-opioid receptor selectively blocks the spinal antinociception induced by delta-, but not mu- or kappa-opioid receptor agonists in the mouse.
Tseng LF; Collins KA; Kampine JP
Eur J Pharmacol; 1994 Jun; 258(1-2):R1-3. PubMed ID: 7925585
[TBL] [Abstract][Full Text] [Related]
10. Spinal delta 2 but not delta 1 opioid receptors are involved in intracerebroventricular beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA; Portoghese PS
Life Sci; 1993; 52(19):PL211-5. PubMed ID: 8387138
[TBL] [Abstract][Full Text] [Related]
11. Antisense oligodeoxynucleotide to a delta-opioid receptor blocks the antinociception induced by cold water swimming.
Mizoguchi H; Narita M; Nagase H; Tseng LF
Regul Pept; 1995 Oct; 59(2):255-9. PubMed ID: 8584762
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
13. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse.
Narita M; Mizoguchi H; Kampine JP; Tseng LF
Br J Pharmacol; 1996 Aug; 118(7):1829-35. PubMed ID: 8842450
[TBL] [Abstract][Full Text] [Related]
14. N-acetyl beta-endorphin-(1-31) and substance P regulate the supraspinal antinociception mediated by mu opioid and alpha-2 adrenoceptors but not by delta opioid receptors in the mouse.
Sánchez-Blázquez P; Garzón J
J Pharmacol Exp Ther; 1993 May; 265(2):835-43. PubMed ID: 7684446
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment with protein kinase C activator phorbol 12,13-dibutyrate attenuates the antinociception induced by mu- but not epsilon-opioid receptor agonist in the mouse.
Narita M; Ohsawa M; Mizoguchi H; Kamei J; Tseng LF
Neuroscience; 1997 Jan; 76(1):291-8. PubMed ID: 8971779
[TBL] [Abstract][Full Text] [Related]
16. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
Suh HH; Tseng LF
J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
[TBL] [Abstract][Full Text] [Related]
17. Nicotine enhances morphine- and beta-endorphin-induced antinociception at the supraspinal level in the mouse.
Suh HW; Song DK; Choi SR; Chung KM; Kim YH
Neuropeptides; 1996 Oct; 30(5):479-84. PubMed ID: 8923511
[TBL] [Abstract][Full Text] [Related]
18. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1993 Sep; 266(3):1430-8. PubMed ID: 8103794
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of antisense oligodeoxynucleotides directed against g(zalpha) and g(oalpha) on antinociception produced by spinal opioid and alpha(2) adrenergic receptor agonists.
Karim F; Roerig SC
Pain; 2000 Aug; 87(2):181-191. PubMed ID: 10924811
[TBL] [Abstract][Full Text] [Related]
20. Treatment with antisense oligodeoxynucleotide to the opioid delta receptor selectively inhibits delta 2-agonist antinociception.
Lai J; Bilsky EJ; Rothman RB; Porreca F
Neuroreport; 1994 May; 5(9):1049-52. PubMed ID: 8080957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
